Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

In a report released today, Craig Irwin from Roth MKM maintained a Buy rating on Plug Power (PLUG – Research Report), with a price target of ...

Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...

Roth MKM analyst George Kelly reiterated a Hold rating on BRC (BRCC – Research Report) today and set a price target of $3.50. The company’s ...

Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Cingulate (NasdaqCM:CING) with a Buy recommendation.

Snap-On Inc (SNA) stock saw a modest uptick, ending the day at $348.5 which represents a slight increase of $2.90 or 0.84% from the prior close of $345.6. The stock opened at $347.63 and touched a low ...

Target (NYSE:TGT – Get Free Report) had its price target upped by stock analysts at Truist Financial from $129.00 to $134.00 ...

Advanced Micro Devices (NASDAQ:AMD – Get Free Report) had its price target dropped by equities researchers at Barclays from ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...

Fintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () (NasdaqGM:VRNA) with a Buy recommendation. As of December 23, 2024, the average ...